Skip to main content
Caplight Logo









Vicora, Inc.

Vicora, Inc.

Private
Buffalo, New YorkHealthcare & Life Scienceshttps://www.vicora.net/

Last Round

Seed Round

Sep 18, 2026

Total Funding Raised

$3.6M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Vicora, Inc. is a medical device company that develops innovative catheter systems for the treatment of vascular diseases, including deep vein thrombosis and pulmonary embolism.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

thrombectomycatheter systemaspiration cathetermedical deviceclot removalvascular diseaseelectroactive polymerpulmonary embolismdeep vein thrombosisDVTinterventional cardiologyinterventional radiologyFDA approvalclot bustermedtech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vicora, Inc. Comparables

Compare Vicora, Inc. with similar companies based on industry and business-model similarity.

Vicora, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Thrombolex, Inc.
90%
Innova Vascular
86%
Akura Medical
83%

Vicora, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundSep 18, 2026
Early FundingMay 9, 2025

Key People

Founding team and executive leadership

Shawn Patterson

Chief Executive Officer

Executive Team

Vicora, Inc. Investors

Notable investors and investment history

Vicora, Inc. investors
InvestorRounds
Egret Healthcare VenturesEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 18, 2026

    $2.3M round completed.

  • Nov 14, 2025

    Grew 60% QoQ from 5 to 8 employees.

Vicora, Inc. Filings

Explore SEC and related filing metadata, where available.

Vicora, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Vicora, Inc.'s valuation, stock price, and market status.

Is Vicora, Inc. a public or private company?

Vicora, Inc. is a private company.

What is the current stock price of Vicora, Inc.?

Vicora, Inc. is a private company, so its shares have no public market price. Caplight tracks Vicora, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Vicora, Inc. worth (valuation)?

Valuation information for Vicora, Inc. is not publicly available.

Can I buy Vicora, Inc. stock?

Vicora, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Vicora, Inc.'s last funding round?

Vicora, Inc.'s most recent funding round was Seed Round on September 18, 2026.

Who are the main investors in Vicora, Inc.?

Key investors in Vicora, Inc. include Egret Healthcare Ventures.

Will Vicora, Inc. IPO soon?

No public IPO plans have been announced for Vicora, Inc..

How can I track Vicora, Inc. secondary market activity?

Caplight tracks bids, offers, and trades in Vicora, Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersBuffalo, New York
Employee Range7
Year Founded2021
Last FundingSep 18, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?